Metraipolis › archive › dc_0fef3ab77906
Oncogenic GPR161 Drives Melanoma Proliferation and Metabolic Activity through TXNIP Inhibition — Europe PMC PMID:41834581
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41834581
- DOI
- 10.4014/jmb.2512.12029
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T20:32:32.273Z
- SHA-256 of the archived text
cb8a0673a52d19cfe126735ed24fba9d69792196c8e29bf00a8eeaeb4a061ea2- Stable URL of this page
https://metraipolis.com/documento/dc_0fef3ab77906
How to cite
Oncogenic GPR161 Drives Melanoma Proliferation and Metabolic Activity through TXNIP Inhibition — Europe PMC PMID:41834581 — Europe PMC (en), https://europepmc.org/article/MED/41834581 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0fef3ab77906 (Metraipolis archive dc_0fef3ab77906, sha256 cb8a0673a52d19cfe126735ed24fba9d69792196c8e29bf00a8eeaeb4a061ea2)
BibTeX
@misc{dc0fef3ab77906,
title = {Oncogenic GPR161 Drives Melanoma Proliferation and Metabolic Activity through TXNIP Inhibition — Europe PMC PMID:41834581},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41834581},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0fef3ab77906; sha256 cb8a0673a52d19cfe126735ed24fba9d69792196c8e29bf00a8eeaeb4a061ea2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41834581. Agents can read the archived copy with the MCP tool read_document.